Fast Assessment of Stroke and Transient ischemic attack to prevent Early Recurrence - Pilot Study "FASTER "


Phase N/A Results

Summary of Purpose

This pilot phase will determine the feasibility of enrolment of patients to a stroke prevention trial within 24 hours of symptom onset and to assess the occurrence of adverse events and laboratory safety of early treatment initiation.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



  • Canadian Stroke Consortium, Canadian Stroke Network, Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Ministry of Health and Long-Term Care Ontario, Merck Research Laboratories.

Trial Design

Multi-center, randomized, double-blind, controlled trial, 2x2 factorial design.


  • Study Director: James Kennedy Nuffield Dept of Clinical Medicine, University of Oxford Phone: +1 (403) 944 4189 Email: Email: